Rafiei, A.; Gualandi, M.; Yang, C.-L.; Woods, R.; Kumar, A.; Brunner, K.; Sigrist, J.; Ebersbach, H.; Coats, S.; Renner, C.;
et al. IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity. Cancers 2024, 16, 2902.
https://doi.org/10.3390/cancers16162902
AMA Style
Rafiei A, Gualandi M, Yang C-L, Woods R, Kumar A, Brunner K, Sigrist J, Ebersbach H, Coats S, Renner C,
et al. IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity. Cancers. 2024; 16(16):2902.
https://doi.org/10.3390/cancers16162902
Chicago/Turabian Style
Rafiei, Anahita, Marco Gualandi, Chia-Lung Yang, Richard Woods, Anil Kumar, Kathrin Brunner, John Sigrist, Hilmar Ebersbach, Steve Coats, Christoph Renner,
and et al. 2024. "IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity" Cancers 16, no. 16: 2902.
https://doi.org/10.3390/cancers16162902
APA Style
Rafiei, A., Gualandi, M., Yang, C.-L., Woods, R., Kumar, A., Brunner, K., Sigrist, J., Ebersbach, H., Coats, S., Renner, C., & Marroquin Belaunzaran, O.
(2024). IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity. Cancers, 16(16), 2902.
https://doi.org/10.3390/cancers16162902